Frontlight ResearchEarly access
TerminatedNo phase
Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders
Key facts
- Who runs it
- Baylor Research Institute
- Where
- Dallas, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 42 people enrolled
- Started
- Jun 2014
- Ended
- Oct 2024
- Type of study
- Interventional
- Treatments tested
- POEM
- Record updated
- 20 March 2025
- Why it stopped
- The study was terminated by the Principal Investigator's to redesign it using more efficient processes.
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Patient with symptomatic achalasia or EGJ outflow obstruction with a motility study, esophagram, and EGD consistent with EGJ outflow obstruction
- Medical indication for surgical myotomy
- Ability to undergo general anesthesia
- Age > 18 yrs. of age and <85 yrs. of age with ability to give informed consent
- Candidate for laparoscopic esophageal myotomy
Who cannot take part
- Previous chest radiotherapy
- Malignant or premalignant esophageal lesion
- Eosinophilic esophagitis
- Barrett's esophagus
- Stricture of esophagus
- Contraindications for EGD
- Unable to provide informed consent
- Pregnancy
Where in United States
- Baylor University Medical CenterDallas, United States
About the trial
What the trial wants to find out
The purpose of this study is to show that the Per-Oral Endoscopic Myotomy (POEM) procedure is an effective treatment for people with achalasia.
The group in the trial
- POEM procedureTreatment being tested
Patients who underwent POEM
Treatment: POEM
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective Evaluation of Per-Oral Endoscopic Myotomy (POEM) of the Lower Esophageal Sphincter for the Treatment of Esophageal Swallowing Disorders
- Record updated
- 20 March 2025